Shaheed W Hakim1, Nicola Schieda2, Taryn Hodgdon3, Matthew D F McInnes4, Marc Dilauro5, Trevor A Flood6. 1. Department of Anatomical Pathology, The Ottawa Hospital, University of Ottawa, 501 Smyth Road, 4 floor CCW, Room 4278, Ottawa, Ontario, Canada, K1Y 4E9. shakim@toh.on.ca. 2. Department of Medical Imaging, The Ottawa Hospital, University of Ottawa, 1053 Carling Avenue, Ottawa, Ontario, Canada, K1Y 4E9. nschieda@toh.on.ca. 3. Department of Medical Imaging, The Ottawa Hospital, University of Ottawa, 1053 Carling Avenue, Ottawa, Ontario, Canada, K1Y 4E9. thodgdon@toh.on.ca. 4. Department of Medical Imaging, The Ottawa Hospital, University of Ottawa, 1053 Carling Avenue, Ottawa, Ontario, Canada, K1Y 4E9. mmcinnes@toh.on.ca. 5. Department of Medical Imaging, The Ottawa Hospital, University of Ottawa, 1053 Carling Avenue, Ottawa, Ontario, Canada, K1Y 4E9. mdilauro@toh.on.ca. 6. Department of Anatomical Pathology, The Ottawa Hospital, University of Ottawa, 501 Smyth Road, 4 floor CCW, Room 4278, Ottawa, Ontario, Canada, K1Y 4E9. tflood@toh.on.ca.
Abstract
OBJECTIVE: To compare imaging findings with histopathology in AML without visible fat (AMLwvf). MATERIAL AND METHODS: With IRB approval, we identified 18 AMLwvf that underwent CT between 2002-2014. A radiologist measured NECT-attenuation, corticomedullary (CM) and nephrographic (NG) enhancement, echogenicity relative to renal cortex (RC) (N = 5), T2W (T2AML/T2RC) signal-intensity (SI), and chemical-shift SI ([SIIN-PHASE - SIOPPOSED-PHASE]/SIIN-PHASE) indices (N = 6). A pathologist re-evaluated 15/18 AMLwvf for 1) < or > 25% adipocytes/high-power-field (HPF), 2) "many or few" blood vessels. Comparisons were performed using chi-square and independent t-tests. RESULTS: 73.3%(11/15) of AMLwvf had <25% adipocytes/HPF and 86.7%(13/15) had "many" blood vessels. NECT-attenuation was 41.8(±6.9) HU. 61.1 %(11/18) of AMLwvf were hyper-attenuating and 38.9%(7/18) iso-attenuating; attenuation was associated with %-adipocytes/HPF, (p = 0.01). CM/NG enhancement were 63.3(±20.8)/51.7(±15.5) HU. 72.2%(13/18) of AMLwvf had wash-out enhancement, with no association with amount of blood vessels at pathology, (p = 0.68). No difference in echogenicity was noted by histology (p > 0.05). All AMLwvf were T2-hypointense (SI ratio = 0.61 [±0.1]). 2/6 AMLwvf showed SI drop on chemical-shift MRI; both were iso-attenuating and were associated with >25% adipocytes/HPF (p = 0.04). CONCLUSIONS: AMLwvf are typically T2-hypointense and hyper-attenuating with wash-out enhancement due to abundant smooth muscle and vessels respectively. Iso-attenuating AMLwvf with microscopic fat on MRI contain more adipocytes/HPF. KEY POINTS: • Five percent of AML do not demonstrate detectable fat on imaging • These AML are hyperattenuating and T2-hypointense due to abundant smooth muscle • These AML show washout enhancement without association to vessel count at histopathology • Iso-attenuating AML with microscopic fat on MRI show >25% adipocytes/HPF • The term "AML without visible fat" is proposed to reduce ambiguity.
OBJECTIVE: To compare imaging findings with histopathology in AML without visible fat (AMLwvf). MATERIAL AND METHODS: With IRB approval, we identified 18 AMLwvf that underwent CT between 2002-2014. A radiologist measured NECT-attenuation, corticomedullary (CM) and nephrographic (NG) enhancement, echogenicity relative to renal cortex (RC) (N = 5), T2W (T2AML/T2RC) signal-intensity (SI), and chemical-shift SI ([SIIN-PHASE - SIOPPOSED-PHASE]/SIIN-PHASE) indices (N = 6). A pathologist re-evaluated 15/18 AMLwvf for 1) < or > 25% adipocytes/high-power-field (HPF), 2) "many or few" blood vessels. Comparisons were performed using chi-square and independent t-tests. RESULTS: 73.3%(11/15) of AMLwvf had <25% adipocytes/HPF and 86.7%(13/15) had "many" blood vessels. NECT-attenuation was 41.8(±6.9) HU. 61.1 %(11/18) of AMLwvf were hyper-attenuating and 38.9%(7/18) iso-attenuating; attenuation was associated with %-adipocytes/HPF, (p = 0.01). CM/NG enhancement were 63.3(±20.8)/51.7(±15.5) HU. 72.2%(13/18) of AMLwvf had wash-out enhancement, with no association with amount of blood vessels at pathology, (p = 0.68). No difference in echogenicity was noted by histology (p > 0.05). All AMLwvf were T2-hypointense (SI ratio = 0.61 [±0.1]). 2/6 AMLwvf showed SI drop on chemical-shift MRI; both were iso-attenuating and were associated with >25% adipocytes/HPF (p = 0.04). CONCLUSIONS: AMLwvf are typically T2-hypointense and hyper-attenuating with wash-out enhancement due to abundant smooth muscle and vessels respectively. Iso-attenuating AMLwvf with microscopic fat on MRI contain more adipocytes/HPF. KEY POINTS: • Five percent of AML do not demonstrate detectable fat on imaging • These AML are hyperattenuating and T2-hypointense due to abundant smooth muscle • These AML show washout enhancement without association to vessel count at histopathology • Iso-attenuating AML with microscopic fat on MRI show >25% adipocytes/HPF • The term "AML without visible fat" is proposed to reduce ambiguity.
Entities:
Keywords:
Angiomyolipoma; Computed tomography; Fat; Magnetic resonance imaging; Ultrasound
Authors: Taryn Hodgdon; Matthew D F McInnes; Nicola Schieda; Trevor A Flood; Leslie Lamb; Rebecca E Thornhill Journal: Radiology Date: 2015-04-23 Impact factor: 11.105
Authors: John Milner; Brian McNeil; Joe Alioto; Kevin Proud; Tara Rubinas; Maria Picken; Terrence Demos; Thomas Turk; Kent T Perry Journal: J Urol Date: 2006-09 Impact factor: 7.450
Authors: Nicole Hindman; Long Ngo; Elizabeth M Genega; Jonathan Melamed; Jesse Wei; Julia M Braza; Neil M Rofsky; Ivan Pedrosa Journal: Radiology Date: 2012-09-25 Impact factor: 11.105
Authors: Nicola Schieda; Taryn Hodgdon; Mohammed El-Khodary; Trevor A Flood; Matthew D F McInnes Journal: AJR Am J Roentgenol Date: 2014-12 Impact factor: 3.959
Authors: Nicola Schieda; Christian B van der Pol; Bardia Moosavi; Matthew D F McInnes; Kien T Mai; Trevor A Flood Journal: Eur Radiol Date: 2015-02-14 Impact factor: 5.315
Authors: Nicola Schieda; Marc Dilauro; Bardia Moosavi; Taryn Hodgdon; Gregory O Cron; Matthew D F McInnes; Trevor A Flood Journal: Eur Radiol Date: 2015-10-20 Impact factor: 5.315
Authors: Bino A Varghese; Frank Chen; Darryl H Hwang; Steven Y Cen; Inderbir S Gill; Vinay A Duddalwar Journal: Br J Radiol Date: 2018-06-21 Impact factor: 3.039
Authors: Massimo Galia; Domenico Albano; Alberto Bruno; Antonino Agrusa; Giorgio Romano; Giuseppe Di Buono; Francesco Agnello; Giuseppe Salvaggio; Ludovico La Grutta; Massimo Midiri; Roberto Lagalla Journal: Br J Radiol Date: 2017-07-13 Impact factor: 3.039
Authors: Matthew S Davenport; Hersh Chandarana; Nicole E Curci; Ankur Doshi; Samuel D Kaffenberger; Ivan Pedrosa; Erick M Remer; Nicola Schieda; Atul B Shinagare; Andrew D Smith; Zhen J Wang; Shane A Wells; Stuart G Silverman Journal: Abdom Radiol (NY) Date: 2018-09
Authors: Robert S Lim; Matthew D F McInnes; Mahadevaswamy Siddaiah; Trevor A Flood; Luke T Lavallee; Nicola Schieda Journal: Eur Radiol Date: 2018-02-28 Impact factor: 5.315
Authors: Nicola Schieda; Matthew S Davenport; Ivan Pedrosa; Atul Shinagare; Hersch Chandarana; Nicole Curci; Ankur Doshi; Gary Israel; Erick Remer; Jane Wang; Stuart G Silverman Journal: J Magn Reson Imaging Date: 2019-01-28 Impact factor: 4.813